Related Experiment Video
Updated: May 7, 2026

NF-κB-dependent Luciferase Activation and Quantification of Gene Expression in Salmonella Infected Tissue Culture Cells
Published on: January 12, 2020
NF-κB RelB negatively regulates osteoblast differentiation and bone formation
Zhenqiang Yao1, Yanyun Li, Xiaoxiang Yin
1Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA; Center for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA.
Nuclear factor-kappa B (NF-κB) RelB protein inhibits bone formation. RelB deficiency in mice leads to increased bone mass and enhanced bone repair, suggesting RelB inhibition for treating bone loss.
Area of Science:
- Cell Biology
- Molecular Biology
- Bone Biology
Background:
- Nuclear factor-kappa B (NF-κB) signaling pathways play critical roles in bone metabolism.
- While RelA-mediated NF-κB signaling is known to affect bone formation, the role of NF-κB RelB in this process remains less understood.
- Previous studies on RelB's role in bone formation utilized complex models and did not elucidate underlying molecular mechanisms.
Purpose of the Study:
- To investigate the role of NF-κB RelB in regulating bone mass and formation.
- To elucidate the molecular mechanisms by which RelB influences osteoblast differentiation and bone repair.
Main Methods:
- Utilized RelB knockout (RelB(-/-)) mice to study age-related bone mass changes.
- Assessed mesenchymal progenitor cell (MPC) proliferation and osteoblast (OB) differentiation in vitro.
- Analyzed the expression of Runt-related transcription factor 2 (Runx2) in RelB(-/-) cells.
- Investigated the direct interaction of RelB with the Runx2 promoter.
- Evaluated bone formation in a murine tibial bone defect model using RelB(-/-) bone-derived MPCs.
Main Results:
- RelB(-/-) mice exhibited increased trabecular bone mass and enhanced bone formation with age.
- RelB(-/-) bone marrow stromal cells showed increased proliferation and enhanced OB differentiation.
- RelB(-/-) cells displayed increased expression of the osteoblastogenic transcription factor Runx2.
- RelB was found to directly target and inhibit the activation of the Runx2 promoter.
- Bone defects healed more rapidly in mice injected with RelB(-/-) MPCs compared to wild-type controls.
Conclusions:
- NF-κB RelB negatively regulates bone mass during aging.
- RelB limits bone formation in healing bone defects.
- Inhibition of RelB presents a potential therapeutic strategy for reducing age-related bone loss and improving bone repair.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Osteoclasts in Bone Remodeling
Co-activators and Co-repressors
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
NF-kB-dependent Signaling Pathway
Bone Remodeling

